GlassScriptPhysician profile
Persis O Williams
NPI 1396742359
$888.46
in general payments reported to CMS, 2019-2025
21 companies · $61.73 in 2025
The $61.73 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $100 · 2021: $191 · 2022: $157 · 2023: $54.77 · 2024: $87.39 · 2025: $61.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $312.20 | 2019-2022 | |
| Allergan, INC. | $93.43 | 2019-2022 | |
| Boston Scientific Corporation | $53.96 | 2021-2022 | |
| Coloplast Corp | $46.54 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $41.57 | 2023-2024 | Pylarify |
| Myriad Genetic Laboratories, INC. | $39.68 | 2024 | Prolaris |
| Urogen Pharma, INC. | $29.66 | 2025 | |
| Abbvie INC. | $24.79 | 2022 | |
| Sumitomo Pharma America, INC. | $23.61 | 2024 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $23.52 | 2020 | |
| Axonics, INC. | $22.75 | 2023 | Axonics |
| Metuchen Pharmaceuticals | $21.98 | 2019 | |
| Urovant Sciences INC | $21.01 | 2022 | |
| Medtronic USA, INC. | $20.45 | 2019 | |
| Blue Earth Diagnostics | $20.21 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $19.70 | 2019 | |
| Cook Medical LLC | $17.17 | 2025 | Litho 150 |
| Tolmar Pharmaceuticals, INC. | $15.69 | 2021 | |
| Medtronic, INC. | $14.90 | 2025 | Interstim |
| Tolmar, INC. | $14.55 | 2023 | |
| Photocure INC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Persis Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.